Postpartum Women's Dexmedetomidine Sedation

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

March 31, 2016

Study Completion Date

April 30, 2016

Conditions
Cesarean Section
Interventions
DRUG

Dexmedetomidine 01

Initial dose of dexmedetomidine was 1.0 μg/kg, with dose adjustment intervals of 0.1μg/kg in first three turning points and 0.05μg/kg in the last four turning points,after the umbilical cord was clapped.The wight used to calculate the dose of dexmedetomidine would be that the total weight of the mother minus the weight of the placenta, amniotic fluid and fetal.

DRUG

Dexmetomidine 02

Initial dose of dexmedetomidine was 1.0 μg/kg, with dose adjustment intervals of 0.1μg/kg in first three turning points and 0.05μg/kg in the last four turning points,as soon as the spinal anesthesia

Trial Locations (1)

510010

Guangzhou Military Region General Hospital, Department of Anesthesiology, Guangzhou

All Listed Sponsors
lead

Guangzhou General Hospital of Guangzhou Military Command

OTHER

NCT02111421 - Postpartum Women's Dexmedetomidine Sedation | Biotech Hunter | Biotech Hunter